Glucose Dependent Insulinotropic Receptor Market, Global Outlook and Forecast 2022-2028

Glucose Dependent Insulinotropic Receptor Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281436 | No. of Pages: 61 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Glucose Dependent Insulinotropic Receptor in Global, including the following market information:
Global Glucose Dependent Insulinotropic Receptor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glucose Dependent Insulinotropic Receptor market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
DA-1241 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glucose Dependent Insulinotropic Receptor include Amgen Inc, Arena Pharmaceuticals Inc, CymaBay Therapeutics Inc, Dong-A Socio Holdings Co Ltd, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Hyundai Pharmaceutical Co Ltd, Kowa Co Ltd and Merck & Co Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glucose Dependent Insulinotropic Receptor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glucose Dependent Insulinotropic Receptor Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Glucose Dependent Insulinotropic Receptor Market Segment Percentages, by Type, 2021 (%)
    DA-1241
    GSK-2041706
    HD-0471042
    HD-0471953
    HOB-047
    MBX-2982
    Others
Global Glucose Dependent Insulinotropic Receptor Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Glucose Dependent Insulinotropic Receptor Market Segment Percentages, by Application, 2021 (%)
    Type 2 Diabetes
    Obesity
    Chronic Obstructive Pulmonary Disease (COPD)
    Dyslipidemia
    Others
Global Glucose Dependent Insulinotropic Receptor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Glucose Dependent Insulinotropic Receptor Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glucose Dependent Insulinotropic Receptor revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glucose Dependent Insulinotropic Receptor revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Amgen Inc
    Arena Pharmaceuticals Inc
    CymaBay Therapeutics Inc
    Dong-A Socio Holdings Co Ltd
    F. Hoffmann-La Roche Ltd
    GlaxoSmithKline Plc
    Hyundai Pharmaceutical Co Ltd
    Kowa Co Ltd
    Merck & Co Inc
    Novartis AG
    Taisho Pharmaceutical Holdings Co Ltd
    Takeda Pharmaceutical Co Ltd
    Yuhan Corp
1 Introduction to Research & Analysis Reports
    1.1 Glucose Dependent Insulinotropic Receptor Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Glucose Dependent Insulinotropic Receptor Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Glucose Dependent Insulinotropic Receptor Overall Market Size
    2.1 Global Glucose Dependent Insulinotropic Receptor Market Size: 2021 VS 2028
    2.2 Global Glucose Dependent Insulinotropic Receptor Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Glucose Dependent Insulinotropic Receptor Players in Global Market
    3.2 Top Global Glucose Dependent Insulinotropic Receptor Companies Ranked by Revenue
    3.3 Global Glucose Dependent Insulinotropic Receptor Revenue by Companies
    3.4 Top 3 and Top 5 Glucose Dependent Insulinotropic Receptor Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Glucose Dependent Insulinotropic Receptor Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Glucose Dependent Insulinotropic Receptor Players in Global Market
        3.6.1 List of Global Tier 1 Glucose Dependent Insulinotropic Receptor Companies
        3.6.2 List of Global Tier 2 and Tier 3 Glucose Dependent Insulinotropic Receptor Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Glucose Dependent Insulinotropic Receptor Market Size Markets, 2021 & 2028
        4.1.2 DA-1241
        4.1.3 GSK-2041706
        4.1.4 HD-0471042
        4.1.5 HD-0471953
        4.1.6 HOB-047
        4.1.7 MBX-2982
        4.1.8 Others
    4.2 By Type - Global Glucose Dependent Insulinotropic Receptor Revenue & Forecasts
        4.2.1 By Type - Global Glucose Dependent Insulinotropic Receptor Revenue, 2017-2022
        4.2.2 By Type - Global Glucose Dependent Insulinotropic Receptor Revenue, 2023-2028
        4.2.3 By Type - Global Glucose Dependent Insulinotropic Receptor Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Glucose Dependent Insulinotropic Receptor Market Size, 2021 & 2028
        5.1.2 Type 2 Diabetes
        5.1.3 Obesity
        5.1.4 Chronic Obstructive Pulmonary Disease (COPD)
        5.1.5 Dyslipidemia
        5.1.6 Others
    5.2 By Application - Global Glucose Dependent Insulinotropic Receptor Revenue & Forecasts
        5.2.1 By Application - Global Glucose Dependent Insulinotropic Receptor Revenue, 2017-2022
        5.2.2 By Application - Global Glucose Dependent Insulinotropic Receptor Revenue, 2023-2028
        5.2.3 By Application - Global Glucose Dependent Insulinotropic Receptor Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Glucose Dependent Insulinotropic Receptor Market Size, 2021 & 2028
    6.2 By Region - Global Glucose Dependent Insulinotropic Receptor Revenue & Forecasts
        6.2.1 By Region - Global Glucose Dependent Insulinotropic Receptor Revenue, 2017-2022
        6.2.2 By Region - Global Glucose Dependent Insulinotropic Receptor Revenue, 2023-2028
        6.2.3 By Region - Global Glucose Dependent Insulinotropic Receptor Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Glucose Dependent Insulinotropic Receptor Revenue, 2017-2028
        6.3.2 US Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.3.3 Canada Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.3.4 Mexico Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Glucose Dependent Insulinotropic Receptor Revenue, 2017-2028
        6.4.2 Germany Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.4.3 France Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.4.4 U.K. Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.4.5 Italy Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.4.6 Russia Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.4.7 Nordic Countries Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.4.8 Benelux Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Glucose Dependent Insulinotropic Receptor Revenue, 2017-2028
        6.5.2 China Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.5.3 Japan Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.5.4 South Korea Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.5.5 Southeast Asia Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.5.6 India Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Glucose Dependent Insulinotropic Receptor Revenue, 2017-2028
        6.6.2 Brazil Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.6.3 Argentina Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Glucose Dependent Insulinotropic Receptor Revenue, 2017-2028
        6.7.2 Turkey Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.7.3 Israel Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.7.4 Saudi Arabia Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
        6.7.5 UAE Glucose Dependent Insulinotropic Receptor Market Size, 2017-2028
7 Players Profiles
    7.1 Amgen Inc
        7.1.1 Amgen Inc Corporate Summary
        7.1.2 Amgen Inc Business Overview
        7.1.3 Amgen Inc Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.1.4 Amgen Inc Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.1.5 Amgen Inc Key News
    7.2 Arena Pharmaceuticals Inc
        7.2.1 Arena Pharmaceuticals Inc Corporate Summary
        7.2.2 Arena Pharmaceuticals Inc Business Overview
        7.2.3 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.2.4 Arena Pharmaceuticals Inc Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.2.5 Arena Pharmaceuticals Inc Key News
    7.3 CymaBay Therapeutics Inc
        7.3.1 CymaBay Therapeutics Inc Corporate Summary
        7.3.2 CymaBay Therapeutics Inc Business Overview
        7.3.3 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.3.4 CymaBay Therapeutics Inc Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.3.5 CymaBay Therapeutics Inc Key News
    7.4 Dong-A Socio Holdings Co Ltd
        7.4.1 Dong-A Socio Holdings Co Ltd Corporate Summary
        7.4.2 Dong-A Socio Holdings Co Ltd Business Overview
        7.4.3 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.4.4 Dong-A Socio Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.4.5 Dong-A Socio Holdings Co Ltd Key News
    7.5 F. Hoffmann-La Roche Ltd
        7.5.1 F. Hoffmann-La Roche Ltd Corporate Summary
        7.5.2 F. Hoffmann-La Roche Ltd Business Overview
        7.5.3 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.5.4 F. Hoffmann-La Roche Ltd Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.5.5 F. Hoffmann-La Roche Ltd Key News
    7.6 GlaxoSmithKline Plc
        7.6.1 GlaxoSmithKline Plc Corporate Summary
        7.6.2 GlaxoSmithKline Plc Business Overview
        7.6.3 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.6.4 GlaxoSmithKline Plc Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.6.5 GlaxoSmithKline Plc Key News
    7.7 Hyundai Pharmaceutical Co Ltd
        7.7.1 Hyundai Pharmaceutical Co Ltd Corporate Summary
        7.7.2 Hyundai Pharmaceutical Co Ltd Business Overview
        7.7.3 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.7.4 Hyundai Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.7.5 Hyundai Pharmaceutical Co Ltd Key News
    7.8 Kowa Co Ltd
        7.8.1 Kowa Co Ltd Corporate Summary
        7.8.2 Kowa Co Ltd Business Overview
        7.8.3 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.8.4 Kowa Co Ltd Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.8.5 Kowa Co Ltd Key News
    7.9 Merck & Co Inc
        7.9.1 Merck & Co Inc Corporate Summary
        7.9.2 Merck & Co Inc Business Overview
        7.9.3 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.9.4 Merck & Co Inc Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.9.5 Merck & Co Inc Key News
    7.10 Novartis AG
        7.10.1 Novartis AG Corporate Summary
        7.10.2 Novartis AG Business Overview
        7.10.3 Novartis AG Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.10.4 Novartis AG Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.10.5 Novartis AG Key News
    7.11 Taisho Pharmaceutical Holdings Co Ltd
        7.11.1 Taisho Pharmaceutical Holdings Co Ltd Corporate Summary
        7.11.2 Taisho Pharmaceutical Holdings Co Ltd Business Overview
        7.11.3 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.11.4 Taisho Pharmaceutical Holdings Co Ltd Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.11.5 Taisho Pharmaceutical Holdings Co Ltd Key News
    7.12 Takeda Pharmaceutical Co Ltd
        7.12.1 Takeda Pharmaceutical Co Ltd Corporate Summary
        7.12.2 Takeda Pharmaceutical Co Ltd Business Overview
        7.12.3 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.12.4 Takeda Pharmaceutical Co Ltd Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.12.5 Takeda Pharmaceutical Co Ltd Key News
    7.13 Yuhan Corp
        7.13.1 Yuhan Corp Corporate Summary
        7.13.2 Yuhan Corp Business Overview
        7.13.3 Yuhan Corp Glucose Dependent Insulinotropic Receptor Major Product Offerings
        7.13.4 Yuhan Corp Glucose Dependent Insulinotropic Receptor Revenue in Global Market (2017-2022)
        7.13.5 Yuhan Corp Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com